If stocks were actually overpriced, there would not be as much merger and acquisition activity, the 'Mad Money' host says.
, is paying a price that is 340% higher than where Medicines was trading at the beginning of the year, Cramer noted. Yet the Swiss pharmaceutical giant still saw its stock rise more than 1% Monday.
But beyond the recently announced deals, Cramer said, the market reaction makes him believe that further acquisitions could be on the horizon. Among the areas he suggested could be ripe for consolidation: some underperforming retail operations, software companies that specifically deal with cybersecurity, and banks, particularly when it comes to smaller, regional players."We have too many payments companies," Cramer said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Iran should punish 'mercenaries' for recent unrest: Guards commanderA senior commander of Iran's Revolutionary Guards has urged the country&03...
Lire la suite »
'Wheel of Fortune' Host Pat Sajak Speaks Out About His Recent Health Scare'Wheel of Fortune' host Pat Sajak had to undergo surgery (and Vanna White had to take over). Here's the latest on the 'Wheel of Fortune' icon and when he'll be returning to the popular game show.
Lire la suite »
Uber slides as London revokes company's license—Cramer and other pros reactUber's conflict with the city of London has come to a head, and experts aren't exactly surprised by the development.
Lire la suite »
'China is the enemy' on trade, not Trump — Cramer blasts media over love of Chinese leader XiCNBC's Jim Cramer says the mainstream media wrongly thinks that ''Xi is a great Chinese man with great Democratic leanings; member of the WTO. And we have a madman as president.''
Lire la suite »
Wendy Williams Is Not Here for Taylor Swift Winning Artist of the Decade“I don’t mean this in a bad way to Taylor … but Artist of the Decade?!” (via toofab)
Lire la suite »